Page Menu

Ashraf Khan

UMassMed Faculty Page


Title: Diagnostic Test for High Risk Premalignant Breast Lesions. UMMS14-69; Patent Pending.

  • The present invention provides an objective biomarker, SFRP1, for the diagnosis of pre-malignant breast lesions also knows as atypical hyperplasias. The technology also discloses a gene expression profile used for predicting the risk that a pre-malignant breast lesion will advance to invasive breast cancer. Further, methods, assays and kits incorporating the SFRP1 biomarker are provided. 


Innovation TopicsDiagnostics, CancerAtypical hyperplasiaBreast cancer  

Additional Resources
click to open search panel